Last reviewed · How we verify
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 Capsule as an Anti-Tussive Agent in Cough Patients: Double Blinded, Randomized, Placebo and Active Rug Comparative, Parallel Designed Phase III Study
This study is for therapeutic confirmation of AG1321001 to evaluate the safety and efficacy as an anti-tussive agent in cough patients.
Details
| Lead sponsor | Ahn-Gook Pharmaceuticals Co.,Ltd |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 396 |
| Start date | 2006-03 |
| Completion | 2007-06 |
Conditions
- Cough
Interventions
- AG1321001(drug)
Primary outcomes
- Cough severity, Cough specific Quality of Life
Countries
South Korea